Cabozantinib Clinical Trial Update

Discussion Board Forums Clinical Trials Cabozantinib Clinical Trial Update

Viewing 5 posts - 31 through 35 (of 35 total)
  • Author
    Posts
  • #79120
    marions
    Moderator

    Ha, ha, the magic wand appeared: we now have a sticky added to this thread.

    Thanks much, dear Rick.

    #79117
    marions
    Moderator

    Caroline…thanks much for the great update. Fingers are crossed for your Mom to continue on with great scan results and no side effects.

    Oh, I will ask Rick to add a Sticky to this thread so that we can (per your suggestion) continue adding information in one place. Thanks for pointing this out.

    Hugs,
    Marion

    #79118
    willow
    Member

    Caroline,
    Thanks for describing this process. I agree with Percy that it helps others greatly to hear about this trial and what it takes for your Mom to participate. All the best to your Mom.
    Willow

    #79119
    pcl1029
    Member

    Hi, Caroline,

    If every caregivers channel their energy like you in reporting your mom’s journey,let other patients and caregivers know about the most up to date effectiveness and/or side effects of the clinical trials; it will surely decrease the anxiety of those who want to participate in such trials. That will be the way for me too if I exhaust all other options.
    Thanks for such easy to read time-line reporting; I sincerely hope that the clinical trial will work for your mom and at the same time increase her quality of life as well. Awaiting good news from you after scanning.

    God bless.

    #9476
    bananaf1sh
    Member

    My mom is on the Cabozantinib clinical trial at Mass General, and I am posting this in the hopes that it’ll be useful for anyone considering the trial. Sorry in advance for the long post. The quick & dirty is that my mom is tolerating the drug well, just as she tolerated being on chemo well.

    Some background information:

    – This clinical trial, though in Phase II, is the first trial where Cabozantinib is being tried on only cholangiocarcinoma patients. The Phase I tested the drug on thousands of other cancer patients with solid tumors to determine the safety in dosage. The Phase II trial is for cc patients for whom one or two treatments with chemotherapy did not work.

    – The trial began in September, 2013. There ARE patients who have been on the drug for at least three months who have not shown progression in the disease, though there are patients whose cancer has progressed and have come off the drug.

    Financial aspects of being on the trial:

    – The trial pays for the drug and any special care (like the 3-day biomarker – see below)
    – Lab tests, scans, stent placements – all these are considered standard care and the patient’s responsibility
    (Also FYI: Hospitals in Massachusetts do not provide any financial assistance to non-MA residents)
    – For those traveling from out-of-state, the Lazarex foundation offers reimbursements on gas (or other travel costs) and lodging

    The trial schedule (my mom will be on the drug for as long as it is effective; one cycle is one month):

    – First week: two visits to get lab work
    – Second & third week: lab work
    – After the third week, lab work every other week
    – CT scan after two cycles, or two months
    – After cycle three, or three months, lab work once a month

    Below is a timeline so far, to indicate how long everything took for my mom to get started on the trial.

    Dec. 23, 2013: My mom finishes her fourth cycle on Gem/Cis.

    Dec. 31, 2013: CT scan on 12/30 reveals an increase in tumor and mets. MSKCC recommends FOLFIRI. I start looking for clinical trials at the recommendation of Percy from the discussion board. I email Dr. Andrew Zhu, the primary investigator of the Cabozantinib clinical trial at Mass General. He emails me back the next day, promising someone from Mass General will get in touch with me.

    Jan. 2, 2014: I get an email from the trial’s coordinating nurse who tells me to establish a medical record number for my mom. They also tell me what they need. I contact my mom’s primary ONC’s office at MSKCC, and they are incredibly helpful about forwarding everything. They tell me Dr. Lipika Goyal, Dr. Zhu’s co-investigator, can see my mom on Jan. 10. I express concern about the possibility of delaying her treatment (following Percy and Marion’s advice), and they move up her appointment to Jan. 7.

    Jan. 7, 2014: Appt at Mass General. We meet with Dr. Goyal and Dr. Hong, a radiologist. I already detailed this meeting in another post. We’re given several options for systemic treatment, one of which is Cabozantinib. My mom signs the consent form to be on the trial the next day & gets blood work done. Dr. Goyal, by the way, turns out to be one of the most compassionate and knowledgeable doctors we’ve met so far on this journey.

    Jan. 21, 2014 (CYCLE 1; Day 1): Blood work at Mass General. Given my mom’s last chemo, this is the earliest she can start taking the pill. She is given a 30-day supply of the pill. She is to take 3 pills a day (60 mg total) every day on an empty stomach (2 hours after eating). She is told not to eat anything for an hour afterwards. She decides that the best time to take the pills is after dinner, before going to bed. This has been working out well.

    Jan. 23, 2014 (3-day biomarker): Blood work at Mass General to see if there are any alarming reactions to the pill. Nothing noteworthy, though maybe a slight increase in tiredness.

    Jan. 28, 2014 (CYCLE 1; Day 8): Blood work at Mass General. Her liver test numbers keep going up, but we’re told that it’s to be expected while on the drug. Her platelets are normal. My mom doesn’t have much to report in terms of side effects, or at least any that the medical team seemed concerned about.

    I know Nicole’s mom (NewfoundLake) is also taking Cabozantinib, and Nikki’s dad (Nikki4470) was considering it. I hope we can keep adding to the post and share as much information as we possibly can.

    Thanks,
    Caroline

Viewing 5 posts - 31 through 35 (of 35 total)
  • You must be logged in to reply to this topic.
©2017 - All Rights Reserved, Cholangiocarcinoma Foundation